Shire Drug Cleared To Treat Binge-eating Disorder

This story is part of the Solving Sacramento journalism collaborative. Solving Sacramento is supported by funding from the James Irvine Foundation and James B. McClatchy Foundation. Our partners include California Groundbreakers, Capital Public Radio, Outword, Russian American Media, Sacramento Business Journal, Sacramento News & Review, Sacramento Observer and Univision 19. About six years ago, Dr.

David Lambert's latest project is building a new prototype of their franchise cafe at Broad Avenue and Tillman Street.

Altschuler said the $54 million in funding "will put rocket boosters under Corner's pioneering work."

Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc.

Scannell Properties of Indianapolis is seeking tenants for a new distribution site the developer plans to build off the Northway.

An Army veteran with a passion for health care wants to make a lasting impact in the state her parents once called home.